| Multiplexed characterization of rationally designed promoter architectures deconstructs combinatorial logic for IPTG-inducible systems TC Yu, WL Liu, MS Brinck, JE Davis, J Shek, G Bower, T Einav, ... Nature communications 12 (1), 325, 2021 | 46 | 2021 |
| Serial quantitation of plasma microbial cell-free DNA before and after diagnosis of pulmonary invasive mold infections after hematopoietic cell transplant MR Heldman, AA Ahmed, W Liu, A Vo, J Keane-Candib, T Stevens-Ayers, ... The Journal of Infectious Diseases 229 (2), 576-587, 2024 | 19 | 2024 |
| Anti-HLA antibodies in recipients of CD19 versus BCMA-targeted CAR T-cell therapy JA Hill, ES Kiem, A Bhatti, W Liu, J Keane-Candib, KS Fitzpatrick, ... American Journal of Transplantation 23 (3), 416-422, 2023 | 11 | 2023 |
| Human herpesvirus-6 reactivation and disease after allogeneic haematopoietic cell transplantation in the era of letermovir for cytomegalovirus prophylaxis E Kampouri, D Zamora, ES Kiem, W Liu, S Ibrahimi, RL Blazevic, ... Clinical Microbiology and Infection 29 (11), 1450. e1-1450. e7, 2023 | 8 | 2023 |
| 2711. Viral encephalitis after chimeric antigen receptor (CAR)-modified T-cell therapy: A Retrospective Cohort Study E Kampouri, E Kiem, A Vo, WL Liu, C Chalal, RS Basom, C Davis, ... Open Forum Infectious Diseases 10 (Supplement_2), ofad500. 2322, 2023 | 1 | 2023 |
| Difficult Encounters in Chronic Pain Patients: A Cohort Study SP Cohen, WL Liu, TL Doshi, EJ Wang, E van Gelderen, R Mawalkar, ... Mayo Clinic Proceedings 100 (1), 30-41, 2025 | | 2025 |
| Off-the-shelf allogeneic natural killer cells for the treatment of COVID-19 WL Liu, E Kampouri, JK Bui, MK Sekhon, A Tercero, D Finlay, ... Molecular Therapy Methods & Clinical Development 32 (4), 2024 | | 2024 |
| Development of web-and mobile-based shared decision-making tools in the neurological intensive care unit WL Liu, L Zhang, S Djamasbi, B Tulu, S Muehlschlegel Neurotherapeutics, e00503, 2024 | | 2024 |
